Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
about
Single cell imaging and quantification of TDP-43 and α-synuclein intercellular propagation.Exploring Braak's Hypothesis of Parkinson's Disease.α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates.The cellular prion protein (PrPC) as neuronal receptor for α-synuclein.Internalization, axonal transport and release of fibrillar forms of alpha-synuclein.Extracellular Vesicles: Unique Intercellular Delivery Vehicles.Selective neuronal vulnerability in Parkinson disease.The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.Alpha-synuclein and iron: two keys unlocking Parkinson's disease.Designer protein disaggregases to counter neurodegenerative disease.Potential Modes of Intercellular α-Synuclein Transmission.LAG3 (CD223) as a cancer immunotherapy target.Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism.TMEM230: How does it fit in the etiology and pathogenesis of Parkinson's disease?Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection.T cells from patients with Parkinson's disease recognize α-synuclein peptides.Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons.Progress toward an integrated understanding of Parkinson's disease.Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegenerationNovel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein.Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model.Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.In vivo models of alpha-synuclein transmission and propagation.Vertebrate food products as a potential source of prion-like α-synuclein.Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.Alpha-synuclein oligomers: a new hope.Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice.Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential.GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers.α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.A network-based meta-analysis for characterizing the genetic landscape of human aging.Parkinson's Disease Is Not Simply a Prion Disorder.Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.Prying into the Prion Hypothesis for Parkinson's Disease.Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.Milestones of Parkinson's Disease Research: 200 Years of History and Beyond.
P2860
Q33674189-2B957EE8-0A3A-40E2-A26D-D66F615BDCDBQ34552244-3E3AACE5-9545-4190-8EAB-41223AC60910Q38601532-1DC22ACE-9557-455B-8C6B-7E20C6861EF4Q38631574-52C5532B-62D1-4D70-AA31-B688801D468DQ38651790-F59F02D8-2141-4D45-8DB9-769BD4382C6FQ38890982-413F5F5B-20B4-4D7F-8B68-8036C62D3C5DQ39039850-6BAFEFF9-98AD-41FA-BC2B-B12253BE7130Q39095738-827B4144-E412-4CC9-B3F5-DE8813F662F6Q39108546-27C3D552-056F-4738-9458-342D6BF99126Q39123736-B21C24F8-96F5-4B1E-AFAF-1E9C47A9F31AQ39139060-69374E5B-37B2-41A6-87C3-8CAAE7A1ABC0Q39152836-C0A5989A-C83A-4AE1-857B-7F61675C0603Q39160974-7BC29936-C9CF-4F74-8EB2-0D7F37605FC8Q39297100-9A69BCCD-2F4B-4C0A-8FA0-6D0EBE3AC292Q39343247-834F3823-35E2-45B5-85CC-8D4E3F1CB547Q40060108-49A5FD3B-647E-40F2-A003-0DFE5CCC911FQ40163812-C653B615-7F38-4366-AC8B-448EEA6CDDA1Q40321151-C9B9CAED-25C5-4070-B293-E91DE9B6203AQ41012014-AA489C3B-712E-4AE1-A2FE-5D089014AF71Q41202092-384325FA-1F0B-483E-8AB6-E552C35E397DQ41311746-D32B1EB4-E5B5-4FE9-8F5E-DB0897630616Q41378010-B5089348-EB0E-45D6-BBC2-2F40532BDE48Q41539639-2C085473-F0A3-421D-B6D9-3D5C4020F32EQ41548991-2073332D-263B-4058-8E05-7B3657514FBCQ46252300-E9DC3BCE-C8ED-4502-90E7-A8C020C63B2EQ46252338-FA61F81D-DECB-4F64-86F5-67806E05441CQ46284513-2E0E6FF4-1031-4CFA-9F66-2B7267378E65Q46321755-6BD8D889-F35D-4A4E-AD86-DCC2A540E26AQ47096063-C655BAB2-78E6-4649-8FC1-863CE06E1CDBQ47123483-31B74480-FAE6-4F35-B7D2-CB5448D33D54Q47124745-D65E7DCF-8DCF-4ED3-A871-BDDAC96032D8Q47193126-E2248F1F-B622-4E02-8BE7-E3A697DC1F76Q47193560-32CB01E7-A04D-4138-B6D8-F4CD8FE2321BQ47261341-51760B81-33A2-4D69-9625-BAC9C6E76A2DQ47314960-1310BA27-5A47-49BC-BEC0-974F288EA868Q47552497-9F24F390-E2DD-4D5D-9668-2C8D759C40C9Q47619917-A2253721-5D6F-464D-A532-04C877A99132Q47665674-147A9C81-06CE-45DF-98F9-89AFF8FE11AEQ47986213-7E1B155C-BA3D-4D52-977F-E811AE4C2897Q48117607-811C05A3-D8C0-48E9-934D-E63520D152D0
P2860
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
@en
type
label
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
@en
prefLabel
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
@en
P2093
P2860
P50
P356
P1433
P1476
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
@en
P2093
Creg J Workman
Dario A A Vignali
Donghoon Kim
George Essien Umanah
Han Seok Ko
Ho Chul Kang
Hyejin Park
James A Keiler
Jianmin Zhang
P2860
P356
10.1126/SCIENCE.AAH3374
P407
P577
2016-09-01T00:00:00Z